Reinhard Dummer

Reinhard Dummer is a European leader in dermatologic oncology who has contributed to clinical research on Merkel cell carcinoma and other rare skin cancers including dermatofibrosarcoma protuberans and advanced cutaneous squamous cell carcinoma. His group at University Hospital Zurich has participated in JAVELIN Merkel 200 and avelumab expansion programs and conducted prospective studies on cemiplimab and other checkpoint inhibitors in rare skin malignancies. He leads an EU-funded rare skin tumor registry and has co-authored international MCC treatment guidelines.